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Abstract 
 
Adaptations to long-term exercise training in type 1 diabetes are sparsely studied. We 
examined the effects of a 1-year individualized training intervention on cardiorespiratory 
fitness, exercise-induced active muscle deoxygenation, and glycemic control in adults with 
and without type 1 diabetes. Eight men with type 1 diabetes (T1D) and eight healthy men 
(CON) matched for age, anthropometry, and peak pulmonary O2 uptake (V̇O2peak), completed 
a 1-year individualized training intervention in an unsupervised real-world setting. Before and 
after the intervention, the subjects performed a maximal incremental cycling test, during 
which alveolar gas exchange (volume turbine and mass spectrometry) and relative 
concentration changes in active leg muscle deoxygenated (∆[HHb]) and total (∆[tHb]) 
hemoglobin (near-infrared spectroscopy) were monitored. Peak O2 pulse, reflecting peak 
stroke volume, was calculated (V̇O2peak/peak heart rate). Glycemic control (glycosylated 
hemoglobin A1c [HbA1c]) was evaluated. Both T1D and CON averagely performed one 
resistance- and 3-4 endurance training sessions per week (~1 h/session  at ~moderate 
intensity). Training increased V̇O2peak in T1D (p=0.004) and CON (p=0.045) (Group×Time 
p=0.677). Peak O2 pulse also rose in T1D (p=0.032) and CON (p=0.018) (Group×Time 
p=0.880). Training increased leg ∆[HHb] at peak exercise in CON (p=0.039) but not in T1D 
(Group×Time p=0.052), while no changes in leg ∆[tHb] at any work rate were observed in 
either group (p>0.05). HbA1c retained unchanged in T1D (from 58±10 to 59±11 mmol/mol, 
p=0.609). In conclusion, one-year adherence to exercise training enhanced cardiorespiratory 
fitness similarly in T1D and CON but had no effect on active muscle deoxygenation or 
glycemic control in T1D. 
Keywords: cardiorespiratory fitness, deoxygenation, diabetes, glycemic control, near-infrared 
spectroscopy
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Introduction 
 
Diabetes is associated with increased cardiovascular risk independent of atherosclerosis, 
dyslipidemia, and hypertension (Fang et al. 2004). Along with its several other health 
benefits, physical activity improves cardiovascular risk factors in type 1 diabetes (Chimen et 
al. 2012). Although a benefit of physical activity on microvascular complications has also 
been questioned (Makura et al. 2013), a favorable effect of physical activity on cardiovascular 
disease in type 1 diabetes has mainly been suggested (Wadén et al. 2008, Tielemans et al. 
2013). Overall, regular physical activity and exercise training are recommended to type 1 
diabetes patients (Chimen et al. 2012, Colberg et al. 2016). 
The risk of cardiovascular complications is strongly predicted by peak pulmonary O2 uptake 
(V̇O2peak), which reflects cardiorespiratory fitness (Kodama et al. 2009). In an integrated 
manner, V̇O2 response to acute exercise is determined by alveolar gas exchange, hemoglobin 
concentration [Hb], cardiac function, muscle blood flow, and muscle O2 extraction and 
utilization (Wagner 1996). While exercise training has been shown to increase V̇O2peak in type 
1 diabetes by short-term studies (Wallberg-Henriksson et al. 1982, Wallberg-Henriksson et al. 
1984, Laaksonen et al. 2000, Rigla et al. 2000, Fuchsjäger-Mayrl et al. 2002, Yardley et al. 
2014), more specific integrated respiratory and cardiovascular adaptations to longer-term (>4 
months) training have not been studied. 
Cardiac dysfunction is characteristic of diabetes (Fang et al. 2004) and impairs systemic O2 
delivery during exercise (Gusso et al. 2012, Rissanen et al. 2015). Peak O2 pulse is an 
estimate of peak left ventricular stroke volume (Whipp et al. 1996) and has been reported to 
rise after aerobic training in type 1 diabetes adults (Rigla et al. 2000). Other human studies of 
cardiac adjustments to exercise training in type 1 diabetes are sparse. Vascular dysfunction is 
also evident in type 1 diabetes (Kindig et al. 1998, Järvisalo et al. 2004, Kivelä et al. 2006, 
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Mason et al. 2006), probably having an independent limiting influence on muscle blood flow 
and therewith O2 delivery also during exercise (Rissanen et al. 2015). Aerobic training 
enhances endothelial function (Fuchsjäger-Mayrl et al. 2002) and leads to muscle capillary 
neoformation (Wallberg-Henriksson et al. 1982) in type 1 diabetes patients, and has also been 
shown to increase the expression of pro-angiogenic genes in type 1 diabetes mice (Kivelä et 
al. 2006). However, animal (Kivelä et al. 2006), cross-sectional (Mason et al. 2006), and 
short-term training intervention (Wallberg-Henriksson et al. 1984) studies have suggested that 
these vascular effects would be deficient relative to individuals without diabetes. Instead, 
subjects with and without type 1 diabetes have displayed a similar training-induced rise in 
enzymatic capacity to utilize O2 (Wallberg-Henriksson et al. 1984). 
The main purpose of the present study was to explore whether a long-term 1-year exercise 
training intervention induces different integrated adaptations of cardiorespiratory fitness, peak 
O2 pulse (indirectly reflecting cardiac pump function), and exercise-induced active muscle 
deoxygenation in adults with and without type 1 diabetes. This study also investigated the 
effect of the 1-year training intervention on glycosylated hemoglobin A1c (HbA1c) because, on 
the one hand, it is uncertain whether regular physical activity can provide a glycemic benefit 
(i.e., reduce HbA1c) in type 1 diabetes (Chimen et al. 2012, Kennedy et al. 2013, Yardley et 
al. 2014), and on the other hand, no long-term training intervention studies have examined the 
issue although such studies would be needed (Kennedy et al. 2013). In addition, a suggested 
inverse association between V̇O2peak and HbA1c (Baldi and Hofman 2010) also justifies 
examining the effects of exercise training on both of the two key variables. 
Based on cardiac impairments (Fang et al. 2004, Gusso et al. 2012, Rissanen et al. 2015) and 
suggested deficient exercise effects on vasculature (Wallberg-Henriksson et al. 1984, Kivelä 
et al. 2006, Mason et al. 2006) in type 1 diabetes, we hypothesized that training would overall 
elicit lesser improvements in V̇O2peak, peak O2 pulse, and active muscle deoxygenation in 
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adults with type 1 diabetes than in well-matched adults with no diabetes. Furthermore, based 
on short-term training intervention studies (Chimen et al. 2012), we expected to observe no 
training-induced reduction of HbA1c in adults with type 1 diabetes. 
 
 
Materials and methods 
 
The present study was a part of an ARTEMIS-Helsinki project, which belonged to a 
Canadian-Finnish collaboration entitled “ARTEMIS – Innovation to Reduce Cardiovascular 
Complications of Diabetes at the Intersection of Discovery, Prevention and Knowledge 
Exchange”. The context, aims, and selected preliminary results of ARTEMIS-Helsinki and 
ARTEMIS have been described elsewhere (Noble et al. 2013). 
 
Subjects and study design 
Forty-two male volunteers were assessed for inclusion in this study: 15 type 1 diabetes 
patients recruited from the patient pool of the FinnDiane Study (Wadén et al. 2005) and 27 
healthy subjects recruited mainly from the employees and the students of University of 
Helsinki, Helsinki, Finland. The exclusion criteria were an age of <18 or >45 years; a 
previous diagnosis or previous clinical evidence of any diabetes-related microvascular 
complication (i.e., nephropathy, neuropathy, retinopathy), hypertension, or any chronic 
disease other than diabetes of the diabetes patients; β-blocker medication; medication 
influencing glucose homeostasis apart from multiple daily insulin injections of the diabetes 
patients; physical disability; substance abuse; smoking; and elite athlete status. Every subject 
gave written informed consent prior to participating in this study, which conformed to the 
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Declaration of Helsinki and was approved by the Ethics Committee of Hospital District of 
Helsinki and Uusimaa, Helsinki, Finland. 
The study flow chart presented in Fig. 1 details the design and flow of this study: After the 
enrollment, exclusions, nonrandomized allocation (i.e., training intervention or no 
intervention), and discontinuations, eight subjects with type 1 diabetes and 13 healthy subjects 
completed a 1-year individualized exercise training intervention. To completely match these 
two training groups for baseline age, anthropometry, and also V̇O2peak, five healthy subjects 
with the highest baseline V̇O2peak values were excluded from further analyses. Consequently, 
eight type 1 diabetes patients (T1D; diabetes onset at the age of 22.9 ± 11.1 years) and eight 
healthy controls (CON) were included in between-group analyses (T1D vs. CON) evaluating 
the effects of the training intervention. Post hoc statistical power calculations proved the 
adequacy of these sample sizes (see Results). 
In addition, five healthy subjects served as Reference group: At baseline and after a 1-year 
period, they went through same clinical measurements as T1D and CON but were only 
instructed to maintain their lifestyle (particularly diet and physical activity) during the period. 
Age and V̇O2peak of Reference group were very different from those of T1D and CON (see 
Results), and the sample size of Reference group (n = 5) remained small. Hence, to avoid 
confounding the between-group analyses (T1D vs. CON) but to demonstrate the repeatability 
of clinical measurements, Reference group was analysed separately from T1D and CON. 
 
Training intervention 
T1D and CON completed a 1-year individualized exercise training intervention in an 
unsupervised real-world setting. Before the intervention, all subjects performed a maximal 
incremental cycling exercise test among other baseline clinical measurements (see below). 
The subjects allocated to training groups were also given a 30-min lecture containing 
Page 6 of 39
research-based justification for general effects and principles of endurance and resistance 
training, and general instructions on adjusting insulin and carbohydrate consumption 
according to physical activity. The lectures were given by exercise physiologists to 1-3 
subjects at a time and also included face-to-face discussions aiming at individual goal setting: 
The overall goal of the intervention was to increase and improve exercise training in real-
world circumstances according to individual’s desires and goals, which were set based on the 
individual results of the baseline measurements. 
During the intervention, the subjects used heart rate monitors (five T1D, six CON: Suunto 
t6c, Suunto Oy, Vantaa, Finland; three T1D, two CON: Polar RS800CX, Polar Electro Oy, 
Kempele, Finland) to collect data (duration, energy expenditure, mean heart rate [HR]) on 
every exercise session in their individual training diaries. The subjects monthly emailed the 
diaries, which included the collected data and information on exercise modes, to the 
researchers, who then emailed individual prescriptive feedback to the subjects. The monthly 
feedback focused on frequency, duration, modes, intensity, and progression of performed 
training. An exercise mode was regarded as 1) endurance training if it included various 
dynamic aerobic and/or anaerobic activities involving large muscle groups (e.g., walking, 
jogging, running, cycling, ball games), and 2) resistance training if it aimed at improving or 
maintaining muscular strength, power, and/or endurance (Howley 2001). Exercise intensity 
was interpreted as % of HR reserve (Howley 2001): % of HRR = (mean HR - resting HR) / 
(peak HR - resting HR) × 100%, where resting HR was the lowest nocturnal HR obtained by 
Firstbeat Bodyguard (Firstbeat Technologies Oy, Jyväskylä, Finland) at the night following 
the maximal incremental cycling exercise test at baseline, and peak HR was the peak HR 
during the baseline exercise test.  
 
Clinical measurements 
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T1D visited the laboratory twice both before (baseline) and after (post) their 1-year training 
intervention. CON and Reference group visited the laboratory once at baseline and twice after 
their 1-year periods of training (CON) or no (Reference group) interventions. The visits were 
preceded by abstinence from physical exercise and alcohol for at least 24 h. At the first visit 
(paid only by T1D at baseline and by all groups after the 1-year periods), the subjects reported 
to the laboratory after overnight fast and their venous blood was drawn for measurement of 
HbA1c. At the second visit, which consisted of pre-exercise measurements and a 
cardiorespiratory exercise test, the subjects reported to the laboratory 2-3 h after an 
unstandardized meal. 
The pre-exercise measurements were preceded by completing a questionnaire on personal 
health and medical history (T1D also reported their daily insulin doses within a 3-day period 
around the second visit). A single question included in the questionnaire was used to enquire 
subjects’ level of leisure-time physical activity (LTPA) at baseline: “If you think about your 
past three months and physical activity sessions lasting more than 20 minutes in all settings 
(e.g., commutation, walking a dog, recreation, sport), how many times a week and how long 
at a time have you engaged in physical activity?”. This question meets the general 
recommendations (i.e., frequency, duration, all settings) for enquiring LTPA (van Poppel et 
al. 2010). The pre-exercise measurements then comprised measuring height, determining 
body composition by the bioimpedance method (InBody 720, Biospace Co., Ltd., Seoul, 
South Korea), measuring thickness of subcutaneous fat with skinfold calipers at the near-
infrared spectroscopy (NIRS) recording site described (see below), obtaining resting 12-lead 
electrocardiography (ECG), measuring resting blood pressure, and performing flow-volume 
spirometry (Medikro Spiro 2000, Medikro Oy, Kuopio, Finland). Additionally, a physician 
examined the subjects to ensure suitability for exercise testing. Capillary blood was drawn 
from a fingertip to analyze glucose concentrations (Glucocard x-meter, Arkray Factor, Inc., 
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Shiga, Japan) before the exercise test; T1D had pre-exercise glucose of 9.2 ± 2.6 mmol/L 
(highest 14.2 mmol/L) at baseline and 8.0 ± 2.1 mmol/L (highest 11.8 mmol/L) after the 
intervention with no ketosis, according to the guidelines at the time when the experiments 
were performed (i.e., between the years 2009-2013) (American Diabetes Association 2004). 
[Hb] was also analyzed (ABL725, Radiometer, Copenhagen, Denmark) from capillary blood. 
The cardiorespiratory exercise test was performed on a cycling ergometer (Monark 
Ergomedic 839E, Monark Exercise AB, Vansbro, Sweden): The test was initiated by 5-min 
rest, while the subjects sat relaxed on the ergometer, and 5-min baseline unloaded cycling, 
after which step incremental exercise (40W / 3 min) was begun with a work rate of 40W. The 
subjects continued exercising until volitional exhaustion. 
Breath-by-breath ventilation was measured by a low-resistance turbine (Triple V, Jaeger 
Mijnhardt, Bunnik, The Netherlands) to determine inspiratory and expiratory flow and 
volumes during the exercise test. Inspired and expired gases were continuously sampled at 
mouth and analyzed for concentrations of O2, CO2, N2, and Ar by mass spectrometry (AMIS 
2000, Innovision A/S, Odense, Denmark) after calibration with precision-analyzed gas 
mixtures. Breath-by-breath respiratory data were collected as raw data, which were 
transferred to a computer to determine gas delays for each breath. This way, the 
concentrations were aligned with volume data, and the profile of each breath was built. 
Breath-by-breath alveolar gas exchange was then calculated with the AMIS algorithms, and 
the data were interpolated to obtain second-by-second values. Pulmonary O2 uptake (V̇O2) 
was analyzed as absolute (L/min) and anthropometry-adjusted (mL/min/kg body weight; 
mL/min/kg fat-free mass [FFM] [Batterham et al. 1999]) values. Respiratory exchange ratio 
(RER) was calculated as a ratio of CO2 output and V̇O2; RER of ≥1.10 was reached in every 
test, suggesting the maximality of the tests performed (Edvardsen et al. 2014). 
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Fingertip pulse oximetry (Nonin 9600, Nonin Medical, Inc., Plymouth, MA) was used to 
monitor arterial O2 saturation (SpO2) during the exercise test, while HR and the electrical 
activity of the heart were monitored by ECG (PowerLab, ADInstruments, Oxford, United 
Kingdom). Systolic and diastolic arterial pressures were measured automatically (Tango+, 
SunTech Medical, Morrisville, NC) from the brachial artery at seated rest and at the end of 
each work rate. Mean arterial pressure (MAP) was calculated: MAP = (systolic blood pressure 
+ 2 × diastolic blood pressure) / 3. Peak O2 pulse was derived by dividing V̇O2peak by peak 
HR (Whipp et al. 1996). 
Active leg muscle deoxygenation, reflecting local imbalance between O2 delivery and 
utilization, was examined during the exercise test using a continuous wave NIRS system 
(Oxymon Mk III Near-Infrared Spectrophotometer, Artinis Medical Systems, Zetten, The 
Netherlands). The NIRS optodes (i.e., one transmitting, one receiving) operated at 
wavelengths of 765 and 860 nm corresponding to the specific extinction coefficients of 
deoxygenated (HHb) and oxygenated hemoglobin (O2Hb), respectively. The NIRS probe, 
housed in an optically dense plastic holder, was attached to the skin by double-sided adhesive 
tape and covered by elastic tape after placing it over the right vastus lateralis (VL) muscle at 
mid-thigh level and parallel to the long axis of the muscle. This anatomical location was 
measured to be the same during baseline- and post-measurements. The inter-optode distance 
was set between 35-45 mm to reach good signal quality before the measurements. The 
principles of NIRS and its applications in exercise physiology have been described elsewhere 
(Ferrari et al. 2004); briefly, the intensity of incident and transmitted light was recorded 
continuously and, along with the specific optical pathlength and extinction coefficients, used 
for on-line estimation and display of relative concentration changes of HHb (∆[HHb]), O2Hb 
(∆[O2Hb]), and total hemoglobin (∆[tHb] = ∆[HHb] + ∆[O2Hb]) from their resting 
concentration levels (i.e., the NIRS device was zeroed at rest). A differential pathlength factor 
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value of 5.51 (Duncan et al. 1995) and a sampling frequency of 10 Hz were used for 
collecting NIRS data. The NIRS data were averaged to give values in 1-s intervals and time-
aligned with the cardiorespiratory data. The averaged ∆[HHb] responses were also 
normalized (%∆[HHb]) so that 0% represents the lowest mean of the last 30 s of any work 
rate and 100% represents the highest mean of the last 30 s of any work rate. 
 
Statistical analysis 
Data are expressed as mean ± standard deviation (SD). The mean values of the last 30 s at 
seated rest, during unloaded cycling, at each work rate, and at peak exercise were included in 
further analyses. V̇O2peak was determined as the highest value of a 60-s moving averaging 
interval. Shapiro-Wilk test was used to check normality and data were log transformed when 
appropriate. One-way ANOVA was used to compare descriptive characteristics and acute 
exercise responses at baseline as well as characteristics of exercise training between T1D and 
CON. One-way repeated-measures ANOVA was used to assess whether within-group 
changes from baseline to post occurred in T1D, CON, or Reference Group. Two-way 
repeated-measures ANOVA was used to evaluate whether there were between-group 
differences in changes from baseline to post between T1D and CON: Group×Time 
interactions were evaluated with Group (T1D vs. CON) as a between-subjects factor and with 
Time (Baseline, Post) as a within-subject factor. If a significant interaction was observed, the 
t-test with Bonferroni correction was used. In case of nonnormally distributed data despite log 
transformation, nonparametric tests were used for between-group (Mann-Whitney U) and 
within-group (Wilcoxon signed-rank) analyses. Associations between key variables were 
examined by Pearson’s correlation coefficient. Standardized effect sizes (ES = mean 
intervention-induced difference / between-subjects SD) were calculated with threshold values 
of ≤0.2 trivial, >0.2 small, >0.6 moderate, and >1.2 large (Hopkins et al. 2009). The results 
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were computed with IBM SPSS Statistics 21 (IBM Corporation, Armonk, NY), while 
statistical significance was set at p < 0.05. 
 
 
Results 
 
Descriptive characteristics 
At baseline, the descriptive characteristics presented in Table 1 were similar between T1D 
and CON. Training increased [Hb] in T1D, absolute forced vital capacity (FVC) in both T1D 
and CON, and FVC (% of reference value) in T1D with no Group×Time interactions. Other 
training effects were not observed in the descriptive characteristics. 
In addition to the data in Table 1, thickness of subcutaneous fat of the VL muscle (9 ± 4 vs. 
13 ± 7 mm, p = 0.410), resting nocturnal HR (51 ± 9 vs. 47 ± 5 bpm, p = 0.251), and resting 
systolic (133 ± 14 vs. 128 ± 11 mmHg, p = 0.514) and diastolic (86 ± 7 vs. 79 ± 16 mmHg, p 
= 0.287) blood pressures were similar for T1D and CON at baseline, respectively. 
Moreover, training decreased basal (baseline: 0.35 ± 0.19 IU/kg/d; change: -0.06 ± 0.06 
IU/kg/d, ES = 1.0, moderate, p < 0.05) but not rapid-acting (baseline: 0.30 ± 0.09 IU/kg/d; 
change: 0.06 ± 0.07 IU/kg/d, p = 0.114) nor total (baseline: 0.65 ± 0.26 IU/kg/d; change: -
0.01 ± 0.09 IU/kg/d, p = 0.867) daily insulin doses of T1D. 
 
Training intervention 
Table 2 shows that: 1) exercise training was similar in T1D and CON in terms of frequency, 
duration, energy expenditure, modes, and intensity; 2) training on average consisted of 3-4 
endurance training sessions and one resistance training session per week; 3) mean training 
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intensity was moderate (Howley 2001); and 4) no consistent progression in training was 
observed within either of the training groups. 
 
Cardiorespiratory adaptations 
At baseline, work rates and cardiorespiratory responses at peak exercise, including V̇O2peak 
(L/min: p = 0.451; mL/min/kg: p = 0.974; mL/min/kg FFM: p = 0.120), were similar between 
T1D and CON (p > 0.05) (Table 3). Training increased peak work rates and V̇O2peak in both 
groups. Specifically, V̇O2peak (mL/min/kg FFM) increased 10% ± 7% in T1D (ES = 1.4, large, 
p = 0.004) and 8% ± 9% in CON (ES = 0.9, moderate, p = 0.045). Additionally, peak O2 pulse 
(mL/beat/kg FFM) rose 10% ± 11% in T1D (ES = 0.9, moderate, p = 0.032) and 11% ± 10% 
in CON (ES = 1.1, moderate, p = 0.018). No significant Group×Time interactions were 
observed for any peak responses, whereas peak MAP was higher in T1D than in CON (p = 
0.016 for the Group effect). 
The magnitude of training-elicited changes in work rates and cardiorespiratory responses at 
peak exercise had no associations with the characteristics of exercise training in T1D (p > 
0.05) (variables in Tables 2 and 3 were examined). On the contrary, consistent associations 
were observed in CON: Percentual change (∆) in peak work rate (W) vs. frequency (r = 0.77, 
p = 0.027), ∆peak work rate (W) vs. duration (r = 0.78, p = 0.022), ∆peak work rate (W/kg 
FFM) vs. duration (r = 0.71, p = 0.048), ∆peak O2 pulse (mL/beat) vs. endurance training 
frequency (r = 0.83, p = 0.043), and ∆peak O2 pulse (mL/beat) vs. duration (r = 0.72, p = 
0.044). The training-induced changes in work rates and cardiorespiratory responses were not 
significantly associated with baseline V̇O2peak (T1D and CON), baseline HbA1c (T1D), 
training-induced change in HbA1c (T1D), nor diabetes duration (T1D) (p > 0.05). 
 
Leg muscle deoxygenation adaptations 
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At baseline, leg muscle %∆[HHb], ∆[HHb], and ∆[tHb] at any work rate were similar 
between T1D and CON (p > 0.05) (Fig. 2 and Fig. 3). Training decreased %∆[HHb] at 
submaximal work rates in CON but not in T1D, while one significant Group×Time interaction 
was observed for %∆[HHb] at 80W (Fig. 2A-B). Within-group changes and Group×Time 
interaction for %∆[HHb] at peak exercise were not significant (p > 0.05). Training increased 
∆[HHb] at peak exercise in CON (ES = 0.5, small, p < 0.039) but not in T1D, and significant 
as well as borderline significant Group×Time interactions were observed for ∆[HHb] at 160W 
and peak exercise, respectively (Fig. 2C-D). No within-group changes or Group×Time 
interactions for ∆[tHb] at any work rate were observed (p > 0.05) (Fig. 3). 
 
Reference group 
At baseline, Reference group aged 28.6 ± 1.0 yrs was younger than CON (p = 0.017) and had 
higher V̇O2peak (54 ± 10 mL/min/kg FFM) than T1D (p = 0.024). Changes in anthropometry, 
hematology, or spirometry were not observed in Reference group after one year (p > 0.05). 
Furthermore, V̇O2peak did not change (+3% ± 6%, p = 0.245), there were no changes in peak 
work rates or cardiorespiratory responses, and no evident changes in leg muscle %∆[HHb], 
∆[HHb], or ∆[tHb] at any work rate were seen in Reference group (p > 0.05). Based on the 
Reference group data, a typical percentage error for V̇O2peak (mL/min/kg FFM) was 2.9% ± 
3.1% (Hopkins 2000). Overall, these data on Reference group reflect the repeatability of the 
methods used in this study. 
 
Statistical power 
Post hoc calculations demonstrated that at least six subjects per group were needed to obtain 
statistical power of 80% for the observed training-elicited change in the main outcome of this 
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study (∆V̇O2peak [mL/min/kg FFM] = 9% ± 8% in a pooled population [T1D+CON], alpha <5 
%). 
 
 
Discussion 
 
The present study demonstrates how the 1-year unsupervised individualized training 
intervention led to equivalent improvements in V̇O2peak in type 1 diabetes patients (T1D) and 
healthy subjects (CON) matched for baseline age, sex, anthropometry, and V̇O2peak. Peak O2 
pulse also increased similarly in the groups, suggesting similar training-induced 
improvements in stroke volume and thus cardiac pump function. Instead, training elevated 
active leg muscle deoxygenation (∆[HHb]) at peak exercise in CON but not in T1D, while no 
training-induced changes in active leg muscle ∆[tHb] at peak exercise or any other work rate 
were observed in either group. These findings together provide the following novel evidence: 
Despite the equivalent training-induced increases in V̇O2peak in adult men with and without 
type 1 diabetes, even long-term training, at least at this volume and intensity, was unable to 
improve NIRS-derived local active muscle O2 extraction in men with type 1 diabetes. 
Meanwhile, no reduction of HbA1c was evident in T1D even after such a long-term training 
intervention. We also observed consistent associations between training dose and training-
induced adaptations in CON but not in T1D. 
Reduced V̇O2peak strongly predicts increased cardiovascular risk (Kodama et al. 2009), which 
is independently pronounced in diabetes (Fang et al. 2004). Accordingly, several studies have 
reported reduced V̇O2peak in both adolescents and adults with type 1 diabetes (Gusso et al. 
2012, Rissanen et al. 2015). However, type 1 diabetes patients are likely capable of attaining 
similar V& O2peak to healthy subjects, but this may depend on them maintaining good glycemic 
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control (Baldi and Hofman 2010). Short-term aerobic training programs of 2-4 months have 
resulted in 6-14% (Wallberg-Henriksson et al. 1982, Wallberg-Henriksson et al. 1984, 
Laaksonen et al. 2000, Rigla et al. 2000) or even 27% (Fuchsjäger-Mayrl et al. 2002) 
increases in V̇O2peak in type 1 diabetes. By contrast, it has remained uncertain whether regular 
physical activity can provide a glycemic benefit (i.e., reduce HbA1c) in type 1 diabetes 
(Chimen et al. 2012, Kennedy et al. 2013, Yardley et al. 2014). The latter uncertainty has 
been supposed to be due to excessive energy consumption around the time of physical activity 
(to meet energetic requirements but particularly to avoid hypoglycemia) and to training-
induced reduction of insulin requirements (Chimen et al. 2012). It has also been postulated 
that previously performed training interventions may have been too short-term to reduce 
HbA1c in this patient group (Kennedy et al. 2013). In the present study, the long-term training 
intervention of one year increased V̇O2peak similarly in T1D (10%) and CON (8%). 
Meanwhile, basal insulin dose decreased in T1D but no changes were observed in their total 
insulin dose or HbA1c. These findings indicate that 1) long-term recreational-like training 
seems to have a similar effect on V̇O2peak in adults with and without type 1 diabetes, 2) even 
long-term training does not reduce HbA1c in adults with type 1 diabetes, and 3) a reduction of 
HbA1c is not thus a prerequisite for nor a consequence of an improvement in V̇O2peak. 
Cardiac dysfunction is characteristic of diabetes (Fang et al. 2004). Diabetes-specific defects 
in cardiac output may include systolic impairments but are primarily due to diastolic 
dysfunction (i.e., reduced ventricular relaxation, preload, and compliance) (Fang et al. 2004), 
the different components of which are manifested also during exercise (Gusso et al. 2012, 
Rissanen et al. 2015). While endurance training has been shown to improve cardiac pump 
function in animal models of type 1 diabetes (Loganathan et al. 2007), human studies 
examining effects of training on cardiac function in type 1 diabetes are sparse. A 10% 
increase in peak O2 pulse, which is an estimate of peak left ventricular stroke volume (Whipp 
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et al. 1996), has been observed after three months of aerobic training in type 1 diabetes adults 
(Rigla et al. 2000). In addition, echocardiography studies in patients with type 2 diabetes have 
produced contradictory findings: Both training-induced improvements (Hollekim-Strand et al. 
2014) and no improvements (Ofstad et al. 2014) in myocardial function have been observed 
with high training intensity possibly leading to more pronounced effects (Hollekim-Strand et 
al. 2014). In the current study, peak O2 pulse rose in a similar manner in the training groups 
(T1D: 10%, CON: 11%) after the long-term one-year exposure to regular exercise, suggesting 
a similar improvement in cardiac pump function in the groups. In addition, no between-group 
differences (i.e., significant Group×Time interactions) in adaptations of peak SpO2, peak HR, 
or [Hb] were present. Thus, accepting both the highly surrogate nature of peak O2 pulse and 
its inability to separate diastolic and systolic components of cardiac function, we suggest that 
the net effect of the 1-year training intervention on the different components of peak systemic 
O2 delivery was equivalent in T1D and CON. However, further human studies providing 
evidence of more detailed cardiac adaptations to exercise training in type 1 diabetes are 
required, particularly because Baldi et al. (2016) have recently reviewed that more vigorous 
exercise may be needed to improve cardiac function in individuals with diabetes. 
In addition to cardiac defects, type 1 diabetes is also characterized by vascular dysfunction 
manifested as endothelial dysfunction (Järvisalo et al. 2004), reduced arterial compliance 
(Mason et al. 2006), decreased capillary-to-fiber ratio (Kivelä et al. 2006), and impaired 
microvascular blood flow (Kindig et al. 1998). These vascular defects are overall reflected by 
our finding of higher MAP at peak exercise in T1D (i.e., significant Group effect), while the 
components of cardiac output (HR and O2 pulse [the surrogate for stroke volume]) were 
similar in T1D and CON. This suggests pronounced peak systemic vascular resistance in 
T1D, thus consistent with our recent study (Rissanen et al. 2015). We also observed that 
training decreased leg muscle %∆[HHb] at submaximal work rates in CON but not in T1D, 
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whereas ∆[HHb] at peak exercise increased only in CON. In other words, maximal 
deoxygenation capacity (i.e., peak ∆[HHb]) of the leg muscle increased only in CON, which 
also led to the decreases in submaximal %∆[HHb] only in CON. 
While the training-induced increase in peak active muscle ∆[HHb] (or [HHb]) has recently 
been reported by cross-sectional studies (using either continuous wave [Rissanen et al. 2012], 
frequency-domain [Boone et al. 2016], or time-resolved [Okushima et al. 2016] NIRS) and a 
longitudinal study (using continuous wave NIRS [Takagi et al. 2016]), it is a novel finding 
that such improvement of local microvascular deoxygenation capacity was totally absent in 
T1D. To explain this we also analyzed the data on leg muscle ∆[tHb], which is a surrogate for 
microvascular blood volume (Ferrari et al. 2004) and reflects local O2 diffusion capacity 
(Groebe and Thews 1990): No increases in ∆[tHb] were observed at peak exercise or any 
other work rate in T1D or CON. This agrees with recent cross-sectional (Okushima et al. 
2016) and longitudinal (Takagi et al. 2016) studies examining the VL muscle and suggests 
that the capacity for diffusive O2 conductance may not be as important for deoxygenation and 
aerobic performance in the VL muscle as it is in some other muscles such as the rectus 
femoris (Okushima et al. 2016). By contrast, another cross-sectional study (Boone et al. 2016) 
illustrated higher [tHb] levels in the VL muscle at peak exercise in individuals with higher 
V̇O2peak compared to less fit individuals. However, the NIRS data of our present study 
indicate that increased local leg muscle O2 extraction mainly explains the training-induced 
increase in peak leg muscle ∆[HHb] in CON. That is to say that training did not improve local 
leg muscle O2 extraction in T1D, whose peak leg muscle ∆[HHb] thus retained unchanged. 
The unaltered O2 extraction in T1D may be explained by their unaltered HbA1c: It has been 
hypothesized that pronounced affinity of glycosylated hemoglobin for O2 is linked with 
blunted microvascular O2 extraction and deoxygenation in the VL muscle at high exercise 
intensities (Tagougui et al. 2015). Theoretically, both deficient muscle fiber type 
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transformation (from type IIb to IIa or even from IIa to I) and/or unaltered enzymatic 
oxidative capacity of muscle mitochondria could also explain the remained level of O2 
extraction in T1D; however, at least the latter of these maladaptations is unlikely as even 
poorly controlled type 1 diabetes patients with HbA1c ~10 % have displayed a normal training 
response in mitochondrial enzyme activities (Wallberg-Henriksson et al. 1984). After all, 
however, any maladaptations in the VL muscle in T1D were not sufficiently severe to prevent 
overall improvements in exercise capacity and cardiorespiratory fitness. 
The main strength and novelty of this study reside in the 1-year duration of the training 
intervention: To our knowledge, no previous studies have examined training-induced 
adaptations of cardiorespiratory fitness or glycemic control after such a long training period in 
patients with type 1 diabetes. This was also the first longitudinal study to examine the effect 
of exercise training on active muscle deoxygenation in individuals with diabetes. Another 
strength of this study was the individual documenting of training that enabled exploring 
associations between the characteristics and the outcomes of training: While different 
characteristics of training had consistent associations with observed training-induced 
adaptations in CON (e.g., the higher the training volume, the greater the increase in peak 
work rate), no such dose-response associations were evident in T1D. This may highlight the 
need for greater individualization of exercise prescription in type 1 diabetes, although it is 
certainly of note that the intervention as such was beneficial also for T1D despite the lack of 
dose-response associations. 
One limitation of the present study is that the allocation of T1D and CON subjects to training 
groups was performed in a nonrandom fashion. This was due to the substantial subject burden 
imposed by the relatively long-term intervention including intensive collecting of individual 
exercise data. While we acknowledge that a randomized design would have been necessary to 
preclude selection bias, the nonrandom allocation hardly affected comparisons between T1D 
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and CON. Regarding the maximality of the exercise tests performed, while our findings of 
RER (≥1.10 reached in every test) suggest the maximality of the tests (Edvardsen et al. 2014), 
a plateau in V̇O2 at high intensities was not observed in five subjects at baseline (three T1D, 
two CON) and four subjects after the intervention (three T1D, one CON), which slightly 
questions the maximality of the nine particular tests (Poole and Jones 2017). It can still be 
argued that as the V̇O2 plateau was absent in only a few subjects including those from both 
T1D and CON, this issue hardly had any effect on our between-group comparisons. Lack of 
consistent progression in training of T1D and CON may also be regarded as a limitation. 
However, more often than not, recreational-like training is certainly characterized by such 
lack of progression. Therewith, the completed training intervention likely reflected real-world 
circumstances, which was one purpose of this study. Furthermore, diet was not controlled 
during the intervention, which also reflects real-world circumstances but completely obviates 
drawing any conclusions regarding the dietary effects on the study outcomes. 
The findings of this study are mainly applicable to nonathlete but already physically active 
adults with relatively well-controlled type 1 diabetes (HbA1c ~7.5 % in T1D) and without 
clinically overt macro- or microvascular complications. In terms of baseline physical activity, 
while self-report and direct measures of physical activity (or exercise training) may differ 
substantially from each other (Prince et al. 2008), our data on self-reported baseline LTPA 
and directly measured exercise training during the intervention suggest that training duration 
(per any time unit) did not increase that much in T1D or CON during the intervention. If this 
was the case, any observed training-induced improvements had to result mainly from long-
term adherence to regular exercising as well as from improvements and individualization of 
other exercise training characteristics (i.e., frequency, modes, intensity). 
In summary, one-year adherence to exercise training, on average consisting of one resistance 
training session and 3-4 endurance training sessions performed per week at ~moderate 
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intensity and for ~one hour at a time, induced similar improvements in V̇O2peak in T1D and 
CON matched for baseline age, sex, anthropometry, and V̇O2peak. This similarity was 
accompanied by equivalent increases in peak O2 pulse. By contrast, training enhanced NIRS-
derived active muscle microvascular O2 extraction at peak exercise in CON but not at all in 
T1D. Meanwhile, no glycemic benefit was evident in T1D even after such a long-term 
training intervention. Furthermore, training was characterized by consistent dose-response 
associations in CON but not in T1D. 
The above-summarized findings provide novel evidence of clinical importance: First, as 
V̇O2peak is known to be a strong predictor of overall cardiovascular risk (Kodama et al. 2009) 
and peak O2 pulse indirectly reflects cardiac pump function capacity (Whipp et al. 1996), it is 
important to observe significant and “normal” training-induced improvements in the two 
variables in individuals with type 1 diabetes given the major burden of cardiovascular 
morbidity in diabetes (Chaturvedi 2007). Second, however, the absence of improvements in 
active muscle microvascular O2 extraction in T1D indicates that even long-term training, at 
least at this volume and intensity, does not induce significant adaptations regarding active 
muscle microvascular O2 delivery and utilization in individuals with diabetes. Particularly in 
this context, it is notable that while improved glycemic control decreases the risk of 
microvascular complications (The Diabetes Control and Complications Trial Research Group 
1993), even long-term training does not seem to reduce HbA1c in adults with type 1 diabetes. 
Third, the lack of dose-response associations in T1D may highlight the need for more 
individualized exercise prescription in type 1 diabetes. 
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Table 1. Descriptive characteristics of the training groups at baseline and after the 
intervention. 
 T1D (n = 8)   CON (n = 8)  p at 
 Baseline Post  Baseline Post Baseline 
a 
Age (yr) 33.4 ± 6.3 34.3 ± 6.4  37.9 ± 7.1 38.9 ± 7.0 0.205 
Diabetes duration (yr) 10.5 ± 6.8 11.4 ± 6.9  - - - 
 (range: 4.0-24.0)      
Anthropometry       
   Weight (kg) 80 ± 11 80 ± 12  86 ± 13 86 ± 10 0.340 
   Height (cm) 180 ± 11 180 ± 11  181 ± 6 181 ± 6 0.713 
   BMI (kg/m
2
) 
b 
24.9 ± 2.8 24.7 ± 3.1  26.3 ± 3.8 26.2 ± 2.8 0.834 
   Body fat (%) 16 ± 5 16 ± 6  21 ± 9 20 ± 7 0.151 
   Fat-free mass (kg) 68 ± 10 67 ± 10  67 ± 7 68 ± 6 0.901 
Hematology       
   [Hb] (g/L) 144 ± 6 150 ± 8†  146 ± 3 
c
 149 ± 10 
c
 0.661 
   HbA1c (mmol/mol) 58 ± 10 
c
 59 ± 11 
c 
‡  - 34 ± 2 - 
   HbA1c (%) 7.3 ± 0.9 
c
 7.5 ± 1.1 
c 
‡  - 5.3 ± 0.2 - 
Spirometry       
   FVC (L) 5.5 ± 0.9 5.6 ± 0.9*  5.6 ± 0.7 5.8 ± 0.6* 0.825 
   FVC (% of 97 ± 12 99 ± 11*  98 ± 12 102 ± 10 0.773 
   reference value)       
   FEV1 (L) 4.5 ± 0.7 4.5 ± 0.7  4.6 ± 0.5 4.6 ± 0.4 0.626 
   FEV1 (% of 96 ± 13 96 ± 13  101 ± 11 100 ± 8 0.411 
   reference value)       
Physical activity       
   LTPA (h:min/wk) 3:28 ± 2:01 - §  4:01 ± 2:00 - § 0.590 
Data are means ± SD. 
a
 Between-group difference at baseline is evaluated with Group (T1D vs. CON) as a between-
subjects factor.
 
b
 Non-normally distributed data: Non-parametric tests are used to compare the groups at 
Baseline (Mann-Whitney U) and Baseline vs. Post (Wilcoxon signed-rank). 
c
 n = 7. 
* Significantly (p < 0.05) different from Baseline. 
† Significantly (p < 0.01) different from Baseline. 
‡ Significantly (p < 0.01) different from CON. 
§ See Table 2 for the details of exercise training during the intervention, please. 
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BMI, body mass index; [Hb], hemoglobin concentration; HbA1c, glycosylated hemoglobin 
A1c; FVC, forced vital capacity; FEV1, forced expiratory volume in one second; LTPA, 
leisure-time physical activity. 
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Table 2. Exercise training performed per month by the training groups during the 
intervention. 
 T1D (n = 8) CON (n = 8) p  
a 
Total volume    
   Frequency (training sessions/mo) 16 ± 4 18 ± 4 0.454 
   Duration (h:min/mo) 16:58 ± 6:07 16:52 ± 4:39 0.967 
   Energy expenditure (kcal/mo) 7759 ± 4540 7762 ± 3812 0.462 
Mode    
   Endurance training frequency (sessions/mo) 13 ± 4 15 ± 6 
b 
0.317 
   Resistance training frequency (sessions/mo) 3 ± 1  3 ± 3 
b
 0.927 
Intensity    
   Mean heart rate (bpm) 122 ± 12 122 ± 6 0.994 
   Mean heart rate (% of HRR) 57 ± 5 55 ± 8 0.553 
Progression    
   The 1st third of the intervention:    
   Energy expenditure (kcal/mo) 
c
 7749 ± 4583 7206 ± 2179 0.529 
   The 2nd third of the intervention:    
   Energy expenditure (kcal/mo) 
c
 6975 ± 3935 8592 ± 5396 0.401 
   The 3rd third of the intervention:    
   Energy expenditure (kcal/mo) 
c
 8610 ± 5637 7342 ± 4408 0.753 
Data are means ± SD. 
a
 Between-group difference is evaluated with Group (T1D vs. CON) as a between-subjects 
factor.
 
b
 n = 6 (two subjects in CON did not report their exercise modes). 
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c
 Non-normally distributed data: Non-parametric Mann-Whitney U test is used to compare the 
groups. 
HRR, heart rate reserve. 
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Table 3. Effects of the training intervention on work rates and cardiorespiratory responses at 
peak exercise. 
 T1D (n = 8)   CON (n = 8)  p for 
 Baseline Post  Baseline Post Group× 
Time  
a
 
Work rate (W) 
b
 237 ± 34 254 ± 27*  255 ± 17 282 ± 36* - 
Work rate 3.5 ± 0.4 3.9 ± 0.5†  3.8 ± 0.3 4.1 ± 0.4* 0.977 
(W/kg FFM)       
V̇O2 (L/min) 3.04 ± 0.60 3.27 ± 0.53*  3.22 ± 0.24 3.53 ± 0.46* 0.567 
V̇O2 (mL/min/kg) 38 ± 4 41 ± 3†  38 ± 4 41 ± 5* 0.916 
V̇O2 45 ± 5 49 ± 6†  48 ± 3 52 ± 5* 0.677 
(mL/min/kg FFM)       
Ventilation (L/min) 130 ± 33 131 ± 31  143 ± 26 146 ± 27 0.750 
SpO2 (%) 96 ± 1 97 ± 2  95 ± 2 95 ± 2 0.632 
Heart rate (bpm) 175 ± 11 173 ± 9  184 ± 12 180 ± 13 0.634 
O2 pulse (mL/beat) 18 ± 4 19 ± 3  18 ± 1 20 ± 2† 0.361 
O2 pulse 0.26 ± 0.03 0.28 ± 0.03*  0.26 ± 0.02 0.29 ± 0.03* 0.880 
(mL/beat/kg FFM)       
MAP (mmHg) § 147 ± 26 
c
 140 ± 10 
c
  131 ± 11 
d
 119 ± 16 
d 
* 0.758 
Data are means ± SD. 
a
 Between-group difference in change from baseline to post is evaluated with Group (T1D vs. 
CON) as a between-subjects factor and Time (Baseline, Post) as a within-subject factor. 
b
 Non-normally distributed data: Non-parametric tests are used to compare the groups (Mann-
Whitney U) and Baseline vs. Post (Wilcoxon signed-rank), and use of repeated-measures 
ANOVA is inappropriate. 
c
 n = 6. 
d
 n = 7. 
* Significantly (p < 0.05) different from Baseline. 
† Significantly (p < 0.01) different from Baseline. 
§ Significant (p < 0.05) difference between T1D and CON. 
FFM, fat-free mass; V̇O2, pulmonary O2 uptake; SpO2, arterial O2 saturation; MAP, mean 
arterial pressure. 
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Figure captions 
 
Fig. 1. Study flow chart. * Five trained healthy subjects with the highest peak pulmonary O2 
uptake (V̇O2peak) values at baseline were excluded from further between-group analyses to 
match the training groups (T1D and CON) also for baseline V̇O2peak. 
 
Fig. 2. Normalized relative (%∆[HHb]) and relative (∆[HHb]) concentration changes in the 
vastus lateralis muscle deoxyhemoglobin as a function of work rate in T1D (A, C; circles) and 
CON (B, D; triangles) at baseline (white plots) and after the 1-year training intervention (= 
Post; black plots). Presented work rates on the x-axis include unloaded cycling (i.e., 0 W), 
work rates accomplished by every subject, and mean peak work rate. Significant within-group 
difference between Baseline and Post (* p < 0.05; † p < 0.01) (one-way repeated-measures 
ANOVA). Significant Group×Time interactions for Leg %∆[HHb] at 80 W (p = 0.047) and 
Leg ∆[HHb] at 160 W (p = 0.029) as well as borderline significant Group×Time interaction 
for Leg ∆[HHb] at peak exercise (p = 0.052) were observed (two-way repeated-measures 
ANOVA). 
 
Fig. 3. Relative concentration changes in the vastus lateralis muscle total hemoglobin 
(∆[tHb]) as a function of work rate in T1D (A; circles) and CON (B; triangles) at baseline 
(white plots) and after the 1-year training intervention (= Post; black plots). Presented work 
rates on the x-axis include unloaded cycling (i.e., 0 W), work rates accomplished by every 
subject, and mean peak work rate. Significant within-group difference between Baseline and 
Post (* p < 0.05) (one-way repeated-measures ANOVA). No significant Group×Time 
interactions for Leg ∆[tHb] at any work rate (p > 0.05) were observed (two-way repeated-
measures ANOVA). 
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Study flow chart. * Five trained healthy subjects with the highest peak pulmonary O2 uptake (V̇O2peak) 
values at baseline were excluded from further between-group analyses to match the training groups (T1D 
and CON) also for baseline V̇O2peak.  
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Normalized relative (%∆[HHb]) and relative (∆[HHb]) concentration changes in the vastus lateralis muscle 
deoxyhemoglobin as a function of work rate in T1D (A, C; circles) and CON (B, D; triangles) at baseline 
(white plots) and after the 1-year training intervention (= Post; black plots). Presented work rates on the x-
axis include unloaded cycling (i.e., 0 W), work rates accomplished by every subject, and mean peak work 
rate. Significant within-group difference between Baseline and Post (* p < 0.05; † p < 0.01) (one-way 
repeated-measures ANOVA). Significant Group×Time interactions for Leg %∆[HHb] at 80 W (p = 0.047) and 
Leg ∆[HHb] at 160 W (p = 0.029) as well as borderline significant Group×Time interaction for Leg ∆[HHb] at 
peak exercise (p = 0.052) were observed (two-way repeated-measures ANOVA).  
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Relative concentration changes in the vastus lateralis muscle total hemoglobin (∆[tHb]) as a function of 
work rate in T1D (A; circles) and CON (B; triangles) at baseline (white plots) and after the 1-year training 
intervention (= Post; black plots). Presented work rates on the x-axis include unloaded cycling (i.e., 0 W), 
work rates accomplished by every subject, and mean peak work rate. Significant within-group difference 
between Baseline and Post (* p < 0.05) (one-way repeated-measures ANOVA). No significant Group×Time 
interactions for Leg ∆[tHb] at any work rate (p > 0.05) were observed (two-way repeated-measures 
ANOVA).  
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